孤儿药物认定-话题@MedSci

#孤儿药物认定#

18篇内容 | 1033人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1615970, encodeId=260a16159e035, content=<a href='/topic/show?id=519345433ea' target=_blank style='color:#2F92EE;'>#孤儿药物认定#</a>, objectTitle=关注罕见病“真性红细胞增多症”：PTG-300获美国FDA孤儿药物认定, objectType=article, longId=196104, objectId=ff9919610447, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff9919610447, replyNumber=0, likeNumber=78, createdTime=2020-06-20, rootId=0, userName=若水129, userId=8cfd19711155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff9919610447, moduleTitle=关注罕见病“真性红细胞增多症”：PTG-300获美国FDA孤儿药物认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff9919610447)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615969, encodeId=310d161596945, content=<a href='/topic/show?id=519345433ea' target=_blank style='color:#2F92EE;'>#孤儿药物认定#</a>, objectTitle=抗体药物偶联物OBI-999治疗胰腺癌获得FDA孤儿药物认定, objectType=article, longId=185335, objectId=6cc718533567, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cc718533567, replyNumber=0, likeNumber=63, createdTime=2019-12-29, rootId=0, userName=若水129, userId=8cfd19711155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cc718533567, moduleTitle=抗体药物偶联物OBI-999治疗胰腺癌获得FDA孤儿药物认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cc718533567)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615968, encodeId=f2a21615968f7, content=<a href='/topic/show?id=519345433ea' target=_blank style='color:#2F92EE;'>#孤儿药物认定#</a>, objectTitle=3D生物打印取得里程碑式进展：FDA授予AuriNovo孤儿药物认定用于小耳畸形患者的耳部重建, objectType=article, longId=183363, objectId=3740183363d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3740183363d9, replyNumber=0, likeNumber=73, createdTime=2019-11-23, rootId=0, userName=若水129, userId=8cfd19711155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3740183363d9, moduleTitle=3D生物打印取得里程碑式进展：FDA授予AuriNovo孤儿药物认定用于小耳畸形患者的耳部重建, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3740183363d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615967, encodeId=3ee4161596eab, content=<a href='/topic/show?id=519345433ea' target=_blank style='color:#2F92EE;'>#孤儿药物认定#</a>, objectTitle=Satralizumab获得日本孤儿药物认定，用以治疗视网膜神经脊髓炎和神经脊髓炎视觉障碍, objectType=article, longId=179454, objectId=c7ad1e945427, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7ad1e945427, replyNumber=0, likeNumber=58, createdTime=2019-09-16, rootId=0, userName=若水129, userId=8cfd19711155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7ad1e945427, moduleTitle=Satralizumab获得日本孤儿药物认定，用以治疗视网膜神经脊髓炎和神经脊髓炎视觉障碍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7ad1e945427)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615966, encodeId=8619161596694, content=<a href='/topic/show?id=519345433ea' target=_blank style='color:#2F92EE;'>#孤儿药物认定#</a>, objectTitle=急性髓细胞白血病的治疗药物或将再添新成员：MB-102（CD123 CAR T）获FDA孤儿药物认定, objectType=article, longId=176182, objectId=3d741e61824e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d741e61824e, replyNumber=0, likeNumber=0, createdTime=2019-07-27, rootId=0, userName=若水129, userId=8cfd19711155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d741e61824e, moduleTitle=急性髓细胞白血病的治疗药物或将再添新成员：MB-102（CD123 CAR T）获FDA孤儿药物认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d741e61824e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615965, encodeId=6d0d161596562, content=<a href='/topic/show?id=519345433ea' target=_blank style='color:#2F92EE;'>#孤儿药物认定#</a>, objectTitle=Menin-MLL抑制剂KO-539获FDA的孤儿药物认定用于治疗急性髓细胞白血病, objectType=article, longId=176178, objectId=4e8f1e617823, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e8f1e617823, replyNumber=0, likeNumber=69, createdTime=2019-07-27, rootId=0, userName=若水129, userId=8cfd19711155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e8f1e617823, moduleTitle=Menin-MLL抑制剂KO-539获FDA的孤儿药物认定用于治疗急性髓细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e8f1e617823)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615964, encodeId=ae91161596424, content=<a href='/topic/show?id=519345433ea' target=_blank style='color:#2F92EE;'>#孤儿药物认定#</a>, objectTitle=耐药性慢性粒细胞白血病的治疗契机：FDA已授予SCO-088孤儿药物认定, objectType=article, longId=175076, objectId=bb051e507623, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb051e507623, replyNumber=0, likeNumber=80, createdTime=2019-07-11, rootId=0, userName=若水129, userId=8cfd19711155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb051e507623, moduleTitle=耐药性慢性粒细胞白血病的治疗契机：FDA已授予SCO-088孤儿药物认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb051e507623)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615963, encodeId=94ae1615963b7, content=<a href='/topic/show?id=519345433ea' target=_blank style='color:#2F92EE;'>#孤儿药物认定#</a>, objectTitle=急性髓细胞白血病的治疗：FDA授予BST-236孤儿药物认定, objectType=article, longId=167756, objectId=3be616e75661, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3be616e75661, replyNumber=0, likeNumber=88, createdTime=2019-06-07, rootId=0, userName=若水129, userId=8cfd19711155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3be616e75661, moduleTitle=急性髓细胞白血病的治疗：FDA授予BST-236孤儿药物认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3be616e75661)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615962, encodeId=968a16159621e, content=<a href='/topic/show?id=519345433ea' target=_blank style='color:#2F92EE;'>#孤儿药物认定#</a>, objectTitle=囊性纤维化候选药物SNSP113获得欧盟孤儿药物认定, objectType=article, longId=164117, objectId=60a716411e78, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60a716411e78, replyNumber=0, likeNumber=68, createdTime=2019-04-13, rootId=0, userName=若水129, userId=8cfd19711155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60a716411e78, moduleTitle=囊性纤维化候选药物SNSP113获得欧盟孤儿药物认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60a716411e78)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615961, encodeId=b6c8161596147, content=<a href='/topic/show?id=519345433ea' target=_blank style='color:#2F92EE;'>#孤儿药物认定#</a>, objectTitle=FDA授予CNP孤儿药物认定用以治疗软骨发育不全, objectType=article, longId=161546, objectId=17ec1615463d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17ec1615463d, replyNumber=0, likeNumber=82, createdTime=2019-03-04, rootId=0, userName=若水129, userId=8cfd19711155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17ec1615463d, moduleTitle=FDA授予CNP孤儿药物认定用以治疗软骨发育不全, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17ec1615463d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615960, encodeId=389c16159609e, content=<a href='/topic/show?id=519345433ea' target=_blank style='color:#2F92EE;'>#孤儿药物认定#</a>, objectTitle=PledPharma在美国为Aladote申请孤儿药物认定, objectType=article, longId=156684, objectId=4954156684c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4954156684c0, replyNumber=0, likeNumber=68, createdTime=2018-12-27, rootId=0, userName=若水129, userId=8cfd19711155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4954156684c0, moduleTitle=PledPharma在美国为Aladote申请孤儿药物认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4954156684c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615959, encodeId=2f46161595981, content=<a href='/topic/show?id=519345433ea' target=_blank style='color:#2F92EE;'>#孤儿药物认定#</a>, objectTitle=APL-2获得FDA的孤儿药物认定用于治疗C3肾小球病, objectType=article, longId=156443, objectId=a73015644339, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a73015644339, replyNumber=0, likeNumber=68, createdTime=2018-12-24, rootId=0, userName=若水129, userId=8cfd19711155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a73015644339, moduleTitle=APL-2获得FDA的孤儿药物认定用于治疗C3肾小球病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a73015644339)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615958, encodeId=244c16159584a, content=<a href='/topic/show?id=519345433ea' target=_blank style='color:#2F92EE;'>#孤儿药物认定#</a>, objectTitle=Cytori 旗下ATI-1123获得FDA孤儿药物认定, objectType=article, longId=149087, objectId=990a14908e6b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=990a14908e6b, replyNumber=0, likeNumber=69, createdTime=2018-09-20, rootId=0, userName=若水129, userId=8cfd19711155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=990a14908e6b, moduleTitle=Cytori 旗下ATI-1123获得FDA孤儿药物认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=990a14908e6b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615957, encodeId=897a161595ecf, content=<a href='/topic/show?id=519345433ea' target=_blank style='color:#2F92EE;'>#孤儿药物认定#</a>, objectTitle=PLN-74809获得FDA孤儿药物认定用于治疗特发性肺纤维化, objectType=article, longId=146127, objectId=56de14612e03, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56de14612e03, replyNumber=0, likeNumber=55, createdTime=2018-08-09, rootId=0, userName=若水129, userId=8cfd19711155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56de14612e03, moduleTitle=PLN-74809获得FDA孤儿药物认定用于治疗特发性肺纤维化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56de14612e03)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615956, encodeId=c969161595634, content=<a href='/topic/show?id=519345433ea' target=_blank style='color:#2F92EE;'>#孤儿药物认定#</a>, objectTitle=Alteogen的抗体-药物偶联物获得FDA孤儿药物认定用于胃癌治疗, objectType=article, longId=146125, objectId=8c3e146125c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c3e146125c7, replyNumber=0, likeNumber=80, createdTime=2018-08-09, rootId=0, userName=若水129, userId=8cfd19711155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c3e146125c7, moduleTitle=Alteogen的抗体-药物偶联物获得FDA孤儿药物认定用于胃癌治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c3e146125c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615955, encodeId=d5151615955fd, content=<a href='/topic/show?id=519345433ea' target=_blank style='color:#2F92EE;'>#孤儿药物认定#</a>, objectTitle=美国食品和药物管理局（FDA）已授予PharmaMar的Lurbinectedin孤儿药物认定, objectType=article, longId=145959, objectId=fbd114595986, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fbd114595986, replyNumber=0, likeNumber=65, createdTime=2018-08-07, rootId=0, userName=若水129, userId=8cfd19711155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fbd114595986, moduleTitle=美国食品和药物管理局（FDA）已授予PharmaMar的Lurbinectedin孤儿药物认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fbd114595986)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615954, encodeId=f6b9161595449, content=<a href='/topic/show?id=519345433ea' target=_blank style='color:#2F92EE;'>#孤儿药物认定#</a>, objectTitle=欧盟对Trovagene的PCM-075孤儿药物认定持积极意见, objectType=article, longId=145740, objectId=e50a145e400e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e50a145e400e, replyNumber=0, likeNumber=94, createdTime=2018-08-04, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e50a145e400e, moduleTitle=欧盟对Trovagene的PCM-075孤儿药物认定持积极意见, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e50a145e400e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1615953, encodeId=91d31615953a0, content=<a href='/topic/show?id=519345433ea' target=_blank style='color:#2F92EE;'>#孤儿药物认定#</a>, objectTitle=Asceneuron的ASN120290从FDA获得了进行性核上性麻痹的孤儿药物认定, objectType=article, longId=145483, objectId=2897145483bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2897145483bf, replyNumber=0, likeNumber=64, createdTime=2018-07-31, rootId=0, userName=若水129, userId=8cfd19711155, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2897145483bf, moduleTitle=Asceneuron的ASN120290从FDA获得了进行性核上性麻痹的孤儿药物认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2897145483bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

孤儿药物认定

2020-05-29

若水129 (审核中...)

前往app查看评论内容

#孤儿药物认定#

关注罕见病“真性红细胞增多症”：PTG-300获美国FDA孤儿药物认定

2020-06-20

若水129 (审核中...)

前往app查看评论内容

#孤儿药物认定#

抗体药物偶联物OBI-999治疗胰腺癌获得FDA孤儿药物认定

2019-12-29

若水129 (审核中...)

前往app查看评论内容

#孤儿药物认定#

3D生物打印取得里程碑式进展：FDA授予AuriNovo孤儿药物认定用于小耳畸形患者的耳部重建

2019-11-23

若水129 (审核中...)

前往app查看评论内容

#孤儿药物认定#

Satralizumab获得日本孤儿药物认定，用以治疗视网膜神经脊髓炎和神经脊髓炎视觉障碍

2019-09-16

若水129 (审核中...)

前往app查看评论内容

#孤儿药物认定#

急性髓细胞白血病的治疗药物或将再添新成员：MB-102（CD123 CAR T）获FDA孤儿药物认定

2019-07-27

若水129 (审核中...)

前往app查看评论内容

#孤儿药物认定#

Menin-MLL抑制剂KO-539获FDA的孤儿药物认定用于治疗急性髓细胞白血病

2019-07-27

若水129 (审核中...)

前往app查看评论内容

#孤儿药物认定#

耐药性慢性粒细胞白血病的治疗契机：FDA已授予SCO-088孤儿药物认定

2019-07-11

若水129 (审核中...)

前往app查看评论内容

#孤儿药物认定#

急性髓细胞白血病的治疗：FDA授予BST-236孤儿药物认定

2019-06-07

若水129 (审核中...)

前往app查看评论内容

#孤儿药物认定#

囊性纤维化候选药物SNSP113获得欧盟孤儿药物认定

2019-04-13

若水129 (审核中...)

前往app查看评论内容

#孤儿药物认定#

FDA授予CNP孤儿药物认定用以治疗软骨发育不全

2019-03-04

若水129 (审核中...)

前往app查看评论内容

#孤儿药物认定#

PledPharma在美国为Aladote申请孤儿药物认定

2018-12-27

若水129 (审核中...)

前往app查看评论内容

#孤儿药物认定#

APL-2获得FDA的孤儿药物认定用于治疗C3肾小球病

2018-12-24

若水129 (审核中...)

前往app查看评论内容

#孤儿药物认定#

Cytori 旗下ATI-1123获得FDA孤儿药物认定

2018-09-20

若水129 (审核中...)

前往app查看评论内容

#孤儿药物认定#

PLN-74809获得FDA孤儿药物认定用于治疗特发性肺纤维化

2018-08-09

若水129 (审核中...)

前往app查看评论内容

#孤儿药物认定#

Alteogen的抗体-药物偶联物获得FDA孤儿药物认定用于胃癌治疗

2018-08-09

若水129 (审核中...)

前往app查看评论内容

#孤儿药物认定#

美国食品和药物管理局（FDA）已授予PharmaMar的Lurbinectedin孤儿药物认定

2018-08-07

仁医06 (审核中...)

前往app查看评论内容

#孤儿药物认定#

欧盟对Trovagene的PCM-075孤儿药物认定持积极意见

2018-08-04

若水129 (审核中...)

前往app查看评论内容

#孤儿药物认定#

Asceneuron的ASN120290从FDA获得了进行性核上性麻痹的孤儿药物认定

2018-07-31

科室
- - 订阅+
  - 更多科室
工具
服务